Clinical Trial Update: Haloperidol for Delirium in Adult Critically Ill Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating haloperidol for delirium in adult critically ill patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Decline
• Cognitive Impairment
• Critical Illness
• Delirium
• Intensive Care Psychosis

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Delirium, Critical Illness | Phase 3 | Status: TERMINATED